Full-Time

Utilities Technician

Capital Projects Focused, X 5 Shift

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Junior, Mid

Dublin, Ireland

In Person

Category
Mechanical Maintenance and Reliability Engineering
Mechanical Engineering
Requirements
  • Time served craft electrician
  • Relevant experience in the portfolio project area(s) and Biopharma installations is an advantage
  • Relevant experience in UPS systems, Diesel Generators, 10 KV switching is an advantage
  • Demonstrated track record of meeting targets and adhering to compliance requirements
  • Ability to keep calm under pressure
  • Strong problem-solving skills
  • Logical thinker
  • Continuous Improvement mindset
  • Self-starter
  • Passion for success in role
  • Ability to troubleshoot complex issues, prioritise
  • Ability to manage and roll out training to end users
  • Ability to supervise, collaborate with and get the most out of contractors
  • Ability to communicate and collaborate with project, technical and management staff.
Responsibilities
  • Execute permits, review Method Statements, LOTOs, Set To Works, MC walks, Panel testing & certification, Board Energisation as required under the Capital Project portfolio
  • Participate in FATs, SATs and CQV activities
  • Ensure work is completed in a safe compliant manner in accordance with applicable procedures, i.e. handover forms are in place, LOTO, barriers and signage is in use
  • Co-ordinate and manage contractors in a safe, clear, efficient manner
  • Challenge under-performing contractors or elements of the project
  • Coordinate small teams of technicians or vendors/contractors for assigned tasks
  • Member of the Site ERT
  • Attend business critical meetings, project meetings, RCA’s
  • Maintaining schedule attainment while communicating issues and expectations appropriately
  • Interact with various onsite IS & Automation systems, including Maximo, BMS & PCS systems, Onelook Permitting System, Drawing Management system, PME power quality monitoring system and other onsite systems
  • Ensuring planned training for new equipment is rolled out to the technician team
  • Recommend and implement improvement ideas to enhance the mechanical or electrical maintenance aspects of the project
  • Compliant documentation as described above and as per Amgen’s SOPs
  • Give equipment updates including problem statements, works completed and planned works to site management and engineering functions
  • Responsible to aid in the creation of training content and delivery of training
  • Responsible for contribution to SOPs, job plan creation, JHA’s and Maximo implementation.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.